Sativex 2.7 mg (Delta-9-Tetrahydrocannabinol (Cannabis Sativa Extract) SPRAY) 2.7 MG

Sativex 2.7 mg is a buccal spray containing cannabis sativa extract, used for managing specific symptoms. This medication is designed for precise dosing and easy administration.

Strength

2.7 MG

Pack Size

5.5ML

Manufacturer / TM Owner

JAZZ PHARMACEUTICALS OPERATIONS UK LIMITED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Sativex 2.7 mg is primarily used for symptom management in conditions like multiple sclerosis. It is often prescribed for what is Sativex used for, including pain relief and muscle spasticity. The active ingredient, delta-9-tetrahydrocannabinol (THC), interacts with the body's endocannabinoid system to provide therapeutic effects.

Side Effects

Common effects of Sativex 2.7 mg may include dizziness, dry mouth, and fatigue. Some users report feelings of relaxation and reduced muscle stiffness. Individual responses can vary, and effects may differ based on dosage and personal tolerance.

Precautions & Warnings

Sativex 2.7 mg should be used with caution, especially by individuals with a history of mental health conditions or substance abuse. It is important to follow healthcare provider instructions and avoid activities requiring alertness until effects are known. Store the spray at room temperature and keep it out of reach of children.

Avoid Interactions

Sativex 2.7 mg may interact with alcohol, sedatives, and other medications that cause drowsiness. It is advisable to consult a healthcare provider before combining it with other treatments. CYP inhibitors and inducers can also affect its metabolism, so monitoring is recommended.

Frequently Asked Questions

Sativex is used for managing symptoms like pain and muscle spasticity, often in conditions such as multiple sclerosis.

Sativex 2.7 mg is administered as a buccal spray, applied directly into the mouth for absorption.

Common side effects include dizziness, dry mouth, and fatigue. Individual experiences may vary.

Sativex may interact with other medications, especially those that cause drowsiness. Consult a healthcare provider before combining treatments.

Sativex should be stored at room temperature and kept out of reach of children.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.